Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula
- PMID: 2403699
Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula
Abstract
Chronic, nonhealing, cutaneous ulcers are a serious clinical problem. The results of previous studies using platelet-derived wound healing formula (PDWHF), derived from autologous platelets, provided evidence that PDWHF actively stimulates repair of the wound. To test whether or not PDWHF accelerates repair, a prospectively randomized, blinded trial was conducted using a placebo control. A total of 32 patients with chronic, nonhealing, cutaneous wounds of the lower extremity were randomized and treated for eight weeks with PDWHF or placebo. Epithelialization of the wound was the end point of study. In the group who received treatment, 81 per cent of patients had epithelialization in eight weeks compared with 15 per cent in the control group (p less than 0.0001). After crossover to treatment with PDWHF, all of the patients in the control group had epithelialization in an average of 7.1 weeks. Regression analysis of the rates of epithelialization also showed significant differences during the initial eight week trial and showed no difference after crossover of the control group to therapy with PDWHF. Results from this study demonstrate a highly statistically significant effect of topically applied platelet-derived growth factors on the repair of chronic, nonhealing, cutaneous ulcers.
Similar articles
-
A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report.J Vasc Surg. 1991 Oct;14(4):526-32; discussion 532-6. J Vasc Surg. 1991. PMID: 1920650 Clinical Trial.
-
Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers.Surgery. 1990 Sep;108(3):508-12. Surgery. 1990. PMID: 2396195
-
[Clinical study of various growth factors on the improvement of impaired healing ulcers in patients with diabetic disease].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1999 Sep;13(5):273-7. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1999. PMID: 12080817 Chinese.
-
The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.Clin Podiatr Med Surg. 2001 Jan;18(1):189-209, viii. Clin Podiatr Med Surg. 2001. PMID: 11344978 Review.
-
Successful methods of treating leg ulcers. The tried and true, plus the novel and new.Postgrad Med. 1999 May 1;105(5):159-61, 165-6, 173-4 passim. doi: 10.3810/pgm.1999.05.1.744. Postgrad Med. 1999. PMID: 10335328 Review.
Cited by
-
Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.Ann Surg. 2000 Apr;231(4):600-11. doi: 10.1097/00000658-200004000-00020. Ann Surg. 2000. PMID: 10749622 Free PMC article. Clinical Trial.
-
Histopathologic Evaluation of Hyaluronic Acid and Plasma-Rich Platelet Injection into Rabbit Vocal Cords: An Experimental Study.Turk Arch Otorhinolaryngol. 2018 Mar;56(1):30-35. doi: 10.5152/tao.2018.2942. Epub 2018 Mar 1. Turk Arch Otorhinolaryngol. 2018. PMID: 29988271 Free PMC article.
-
The Benefits of Using Platelet-rich Plasma with Dermal Substitutes for Extremity Posttraumatic Skin Defects: A Short-term Outcome.Plast Reconstr Surg Glob Open. 2024 Jan 29;12(1):e5492. doi: 10.1097/GOX.0000000000005492. eCollection 2024 Jan. Plast Reconstr Surg Glob Open. 2024. PMID: 38288418 Free PMC article.
-
Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.J Extra Corpor Technol. 2010 Mar;42(1):20-9. J Extra Corpor Technol. 2010. PMID: 20437788 Free PMC article. Review.
-
Review of Post-laser-resurfacing Topical Agents for Improved Healing and Cosmesis.J Clin Aesthet Dermatol. 2021 Aug;14(8):24-32. Epub 2021 Aug 1. J Clin Aesthet Dermatol. 2021. PMID: 34840654 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical